Ligand Pharmaceuticals
LGND
#3613
Rank
A$5.44 B
Marketcap
A$276.43
Share price
-1.57%
Change (1 day)
48.00%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$93.08 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.25 Billion. In 2024 the company made an earning of A$7.98 Million a decrease over its 2023 earnings that were of A$92.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$93.08 M1065.29%
2024 A$7.98 M-91.37%
2023 A$92.55 M-7.59%
2022 A$0.10 B4%
2021 A$96.3 M296.42%
2020 A$24.29 M-97.97%
2019 A$1.19 B275.62%
2018 A$0.31 B237.48%
2017 A$94.49 M49.05%
2016 A$63.39 M55.41%
2015 A$40.79 M36.87%
2014 A$29.8 M29.59%
2013 A$22.99 M1309.35%
2012 A$1.63 M-43.97%
2011 A$2.91 M-113.19%
2010 -A$22.09 Million59.86%
2009 -A$13.82 Million-61.33%
2008 -A$35.73 Million-58.75%
2007 -A$86.6 Million20.52%
2006 -A$71.85 Million81.27%
2005 -A$39.64 Million
2003 -A$27.6 Million-20.6%
2002 -A$34.76 Million4.38%
2001 -A$33.3 Million-48.83%
2000 -A$65.07 Million-19.74%
1999 -A$81.07 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$44.18 Million-5.83%
1996 -A$46.92 Million136.23%
1995 -A$19.86 Million-33.97%
1994 -A$30.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.61 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.05 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.38 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.86 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.39 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$33.22 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.55 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.41 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$89.05 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA